Resveratrol enhances the suppressive effects of arsenic trioxide on primitive leukemic progenitors

Efforts to enhance the antileukemic properties of arsenic trioxide are clinically relevant and may lead to the development of new therapeutic approaches for the management of certain hematological malignancies. We provide evidence that concomitant treatment of acute myeloid leukemia (AML) cells or chronic myeloid leukemia (CML) cells with resveratrol potentiates arsenic trioxide-dependent induction of apoptosis. Importantly, clonogenic assays in methylcellulose demonstrate potent suppressive effects of the combination of these agents on primitive leukemic progenitors derived from patients with AML or CML. Taken together, these findings suggest that combinations of arsenic trioxide with resveratrol may provide an approach for targeting of early leukemic precursors and, possibly, leukemia initiating stem cells.

[1]  Yujiang Fang,et al.  A potential role for resveratrol as a radiation sensitizer for melanoma treatment. , 2013, The Journal of surgical research.

[2]  M. Yu,et al.  Resveratrol protects against arsenic trioxide-induced nephrotoxicity by facilitating arsenic metabolism and decreasing oxidative stress , 2013, Archives of Toxicology.

[3]  L. Platanias,et al.  Regulation of the kinase RSK1 by arsenic trioxide and generation of antileukemic responses , 2013, Cancer biology & therapy.

[4]  M. Yu,et al.  Resveratrol attenuates hepatotoxicity of rats exposed to arsenic trioxide. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[5]  M. Bogyo,et al.  Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide. , 2012, Blood.

[6]  S. Fulda.  Regulation of cell death and survival by resveratrol: implications for cancer therapy. , 2012, Anti-cancer agents in medicinal chemistry.

[7]  V. Demarco,et al.  Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis , 2012, Cancer science.

[8]  L. Platanias,et al.  Antileukemic effects of AMPK activators on BCR-ABL-expressing cells. , 2011, Blood.

[9]  A. Redig,et al.  Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors , 2011, Clinical Cancer Research.

[10]  R. Larson,et al.  Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. , 2010, Blood.

[11]  L. Platanias,et al.  Autophagy Is a Critical Mechanism for the Induction of the Antileukemic Effects of Arsenic Trioxide* , 2010, The Journal of Biological Chemistry.

[12]  L. Platanias,et al.  Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells , 2010, Proceedings of the National Academy of Sciences.

[13]  L. Platanias,et al.  Arsenic Trioxide-Dependent Activation of Thousand-and-One Amino Acid Kinase 2 and Transforming Growth Factor-β-Activated Kinase 1 , 2010, Molecular Pharmacology.

[14]  G. Robert,et al.  Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. , 2010, Cancer research.

[15]  L. Platanias.  Biological Responses to Arsenic Compounds* , 2009, The Journal of Biological Chemistry.

[16]  A. Kimchi,et al.  Life and death partners: apoptosis, autophagy and the cross-talk between them , 2009, Cell Death and Differentiation.

[17]  R. Arceci.  PML targeting eradicates quiescent leukaemia-initiating cells , 2009 .

[18]  M. Levrero,et al.  Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways. , 2008, Blood.

[19]  S. Grosso,et al.  Imatinib mesylate‐resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  A. Redig,et al.  Regulation of Arsenic Trioxide-induced Cellular Responses by Mnk1 and Mnk2* , 2008, Journal of Biological Chemistry.

[21]  A. Redig,et al.  Regulatory Effects of Mammalian Target of Rapamycin-mediated Signals in the Generation of Arsenic Trioxide Responses* , 2008, Journal of Biological Chemistry.

[22]  A. Redig,et al.  Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL–expressing cells , 2006, Molecular Cancer Therapeutics.

[23]  L. Platanias,et al.  Activation of the Mitogen- and Stress-activated Kinase 1 by Arsenic Trioxide* , 2006, Journal of Biological Chemistry.

[24]  L. Platanias,et al.  Role of the p38 mitogen-activated protein kinase pathway in the generation of arsenic trioxide-dependent cellular responses. , 2006, Cancer research.

[25]  J. Sedlák,et al.  Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells. , 2006, Neoplasma.

[26]  Yuh‐Cheng Yang,et al.  Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation. , 2005, Journal of radiation research.

[27]  Ming-Tsan Lin,et al.  Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells. , 2004, Carcinogenesis.

[28]  S. Fulda,et al.  Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol , 2004, Oncogene.

[29]  S. Minucci,et al.  Activation of Rac1 and the p38 Mitogen-activated Protein Kinase Pathway in Response to Arsenic Trioxide* , 2002, The Journal of Biological Chemistry.

[30]  A. Verma,et al.  Protein Kinase C-δ (PKC-δ) Is Activated by Type I Interferons and Mediates Phosphorylation of Stat1 on Serine 727* , 2002, The Journal of Biological Chemistry.

[31]  J Dörrie,et al.  Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. , 2001, Cancer research.

[32]  L. Platanias,et al.  Activation of the p 38 Mitogen-activated Protein Kinase by Type I Interferons , 1999 .

[33]  Norman R. Farnsworth,et al.  Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.

[34]  I. de Sio,et al.  Effect of metoclopramide on transmural oesophageal variceal pressure and portal blood flow in cirrhotic patients. , 1990, Digestion.

[35]  W. H. Moore,et al.  Dichotic Ear Preferences of Stuttering Children and Adults , 1975, Perceptual and motor skills.